Patents by Inventor Peter Bottini

Peter Bottini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7803838
    Abstract: Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other active agent, wherein the at least one other active agent is a cardiovascular agent.
    Type: Grant
    Filed: May 31, 2005
    Date of Patent: September 28, 2010
    Assignee: Forest Laboratories Holdings Limited
    Inventors: Eric Davis, John O'Donnell, Peter Bottini
  • Publication number: 20090227646
    Abstract: Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other active agent, wherein the at least one other active agent is a cardiovascular agent.
    Type: Application
    Filed: February 6, 2009
    Publication date: September 10, 2009
    Applicant: Mylan Laboratories, Inc.
    Inventors: Eric Davis, John O'Donnell, Peter Bottini
  • Publication number: 20090215844
    Abstract: Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other active agent, wherein the at least one other active agent is a cardiovascular agent.
    Type: Application
    Filed: February 6, 2009
    Publication date: August 27, 2009
    Applicant: Mylan Laboratories, Inc.
    Inventors: Eric Davis, John O'Donnell, Peter Bottini
  • Publication number: 20050272810
    Abstract: Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other active agent, wherein the at least one other active agent is a cardiovascular agent.
    Type: Application
    Filed: May 31, 2005
    Publication date: December 8, 2005
    Inventors: Eric Davis, John O'Donnell, Peter Bottini